Close Menu
Home » Co-Diagnostics Selling $5M of Shares

Co-Diagnostics Selling $5M of Shares

Jan 24, 2020
|
staff reporter

NEW YORK – Molecular diagnostics firm Co-Diagnostics announced Friday that it has entered into a definitive agreement with institutional investors to purchase its stock in a direct offering.

The Salt Lake City, Utah-based firm will sell about 3.5 million shares of its common stock, at $1.45 per share. The offering is expected to close on or about Jan. 28.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Metabolite Trail

The Economist reports that it is increasingly easier to analyze the metabolites people give off, potentially revealing personal information about them.

Just a Few Changes...

A controversial paper on the gender gap in science has been corrected, according to BuzzFeed News.

Not Meeting Standards

The Los Angeles Times reports that only a third of California students meet the state's new science standards.

Science Studies Examine Archaic Admixture in West Africans, Variant Linked to Cannabis Dependence Risk

In Science this week: evidence of interbreeding between the ancestors of West Africans and an unknown archaic human, and more.

Feb
25
Featured Webinar

Long-Read Sequencing of Human Transcription Provides Insights into Metastatic Cancer

Sponsored by
Loop Genomics

This webinar will discuss a study that used long-read transcriptome sequencing to explore the distribution of isoforms in colon cancer samples and their metastasis counterparts. 

Feb
26
Featured Webinar

Transformation of the Lab to Fight Genetic Illnesses in the Amish and Mennonite Populations

Sponsored by
Autogen

This webinar will explain how the Clinic for Special Children in Strasburg, Pennsylvania, has transformed its DNA workflows to improve the diagnosis and treatment of genetic illnesses that are prevalent in the pediatric population of its community.

Feb
27
Featured Webinar

Digital PCR Method Development for Accurate Quantification of Copy Number Variations

Sponsored by
Stilla

Since the publication of the “The Digital MIQE Guidelines: Minimum Information for Publication of Quantitative Digital PCR Experiments” (dMIQE) in 2013, there has been a large expansion of the applications of dPCR such as single nucleotide variations (SNVs) and copy number variations (CNVs) measurements associated with disease diagnostics.

Mar
18
Featured Webinar

Comparison of Genome-Wide versus Targeted cfDNA Testing for First-Line Prenatal Screening: Real-World Data

Sponsored by
Roche

This webinar will discuss data from a recent real-world comparison study evaluating performance of two cell-free DNA methodologies as first-line prenatal screens.

What's Popular?

In PCR

  1. BGI Distributes More Than 230,000 Coronavirus Test Kits

  2. Coronavirus Test Kits Encounter QC Hiccup in Some States, CDC Reports

  3. Diagnostics Firms Rush to Develop Rapid Point-of-Care Tests for Novel Coronavirus

    Premium

  4. Qiagen Readying Updated Respiratory Panel for Emergency 2019-nCoV Testing

  5. Lucid Diagnostics EsoGuard DNA Test Gets FDA Breakthrough Device Status

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.